Topic: Patricia Mcgowan

A COMPOUND that slows the proliferation of triple-negative breast cancer cells in lab tests could lead to the first drugs to target this aggressive type of tumour.. McGowan presented the findings at this week's European Organisation for Research and Treatment of ...